Navigation Links
BellBrook Labs Launches Ultra-Sensitive Methyltransferase Assay to Accelerate Epigenetic Drug Discovery
Date:8/10/2017

BellBrook Labs announces the launch of their latest drug discovery tool, the AptaFluor SAH Methyltransferase Assay, an enabling new high throughput screening (HTS) assay to aid researchers in their search for breakthrough drugs targeting epigenetic pathways that drive cancer and other debilitating diseases.

Chemical modification of gene expression, also known as epigenetics, is perhaps the most promising area for molecularly targeted drug discovery since validation of kinases as drug targets. Methyltransferases are the largest class of epigenetic enzymes, and several have been shown to play a causative role in cancer and other diseases. Several years ago, major drug discovery efforts were initiated using HTS to identify methyltransferase inhibitors, much like the successful approach used for protein kinases. However, due to their intrinsic properties, detection of methyltransferase activity requires extremely sensitive radioactive assays and/or large amounts of methyltransferase enzymes, which made HTS impractical in many instances. For these reasons, there has been a long-standing need for more sensitive, non-radioactive assays to enable robust, cost effective screening of methyltransferase targets.

As a first-of-its-kind homogeneous assay using aptamers (nucleic acid-based affinity reagents) for HTS, the AptaFluor SAH Methyltransferase Assay provides an elegant solution to the cost and sensitivity barriers that were hampering the discovery of methyltransferase inhibitors. Methyltransferases produce a variety of methylated products, but all use S-adenosylmethionine (SAM) as the methyl donor, leaving S-adenosylhomocysteine (SAH) as a common reaction product. The AptaFluor SAH Assay is based on a naturally occurring microbial aptamer, discovered by Yale University professor Ron Breaker, which evolved to recognize SAH with exquisite sensitivity and selectivity.

BellBrook scientists engineered the SAH aptamer to produce a fluorescent signal on binding to SAH, resulting in a non-radioactive assay with unparalleled sensitivity. By directly detecting SAH, the new AptaFluor assay is universal, allowing the researcher to use the assay for virtually any methyltransferase enzyme. The assay utilizes a simple mix-and-read format with a far red positive TR-FRET readout, ensuring its compatibility with automated dispensing equipment and plate readers commonly used for HTS. With this novel assay technology, scientists can now more easily study challenging methyltransferase targets with the efficiency demanded by today’s drug discovery programs.

About BellBrook Labs

BellBrook Labs is dedicated to accelerating drug discovery and biological research by providing innovative high throughput screening solutions. BellBrooks core technology Transcreener® is a universal, homogeneous biochemical assay platform based on detection of nucleotides that makes it easy to screen thousands of different enzymes. These include validated targets like kinases, as well as emerging targets like ATPases, GTPases, methyltransferases, and glycosyltransferases. Detection reagents and drug discovery services from BellBrook Labs help researchers progress toward more effective therapies for cancer and other debilitating diseases.

Read the full story at http://www.prweb.com/releases/New-Methyltransferase/HTS-Assay/prweb14582831.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. BellBrook Labs Expands Drug Discovery Services Portfolio to Include Lead Discovery Services
2. BellBrook Labs Webinar on July 22nd: Simplifying HTS with Orthogonal Pooled Screening
3. BellBrook Labs Teams Up with UW-Madison to Fight Neurodegenerative Diseases using Stem Cells and Microfluidics
4. BellBrook Labs Webinar: Analyzing Kinase Inhibitor Residence Times using the Transcreener® ADP Assay
5. BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening
6. BellBrook Labs Webinar: Transcreener® HTS assays for UDP, GDP, and CMP as a Universal Glycosyltransferase Assay Platform
7. BellBrook Labs and UW-Madison Team Awarded NCI Contract to Develop Next Generation Cancer Models
8. BellBrook Labs Develops a TR-FRET Based Transcreener GTPase Assay
9. BellBrook Labs Seeking Partners to Accelerate Commercialization of Innovative HTS Assay Technologies
10. BellBrook Labs Launches New Turn Key Methyltransferase Assay Kit for Oncogenic Histone Methyltransferase EZH2
11. BellBrook Labs Launches Second Generation Transcreener EPIGEN Methyltransferase Assay to Acclerate Epigenetic Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2017)... and London UK (PRWEB) , ... August 10, 2017 , ... ... will host a new educational webinar to demonstrate how Good Clinical Practice ... contracts, and site documents. In addition the webinar will discuss the importance of GCP ...
(Date:8/10/2017)... FL (PRWEB) , ... August 10, 2017 , ... ... that the stock market news outlet had initiated coverage on Next Group Holdings, ... growing and underserved consumer markets geared toward those that cannot engage in traditional ...
(Date:8/10/2017)... 10, 2017   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... ("BioLife" or the "Company"), today reported operational highlights and ... June 30, 2017. Revenue from biopreservation media ... in the second quarter of 2017, an increase of ...
(Date:8/8/2017)... ... August 08, 2017 , ... This webinar, ... Virtual Event, will discuss Phase Analysis Light Scattering (PALS) and Raman spectroscopy methods ... used to assess vaccine product quality and consistency regarding particle size, zeta potential ...
Breaking Biology Technology:
(Date:3/23/2017)... Research and Markets has announced the addition ... - Industry Forecast to 2025" report to their offering. ... The Global Vehicle ... around 8.8% over the next decade to reach approximately $14.21 billion ... estimates and forecasts for all the given segments on global as ...
(Date:3/22/2017)... 21, 2017 Optimove , provider ... retailers such as 1-800-Flowers and AdoreMe, today announced ... and Replenishment. Using Optimove,s machine learning algorithms, these ... and replenishment recommendations to their customers based not ... of customer intent drawn from a complex web ...
(Date:3/20/2017)... 2017 At this year,s CeBIT Chancellor Dr. ... DERMALOG. The Chancellor came to the DERMALOG stand together with the Japanese ... CeBIT partner country. At the largest German biometrics company the two government ... and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
Breaking Biology News(10 mins):